This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer (DESKTOP III)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
ARCAGY/ GINECO GROUP
MITO
Arbeitsgemeinschaft Gynaekologische Onkologie Austria
GlaxoSmithKline
medac GmbH
Grupo Español de Investigación en Cáncer de Ovario
NSGO
MaNGO
Cancer Research UK
Korean Gynecologic Oncology Group
Shanghai Gynecologic Oncology Group
Information provided by (Responsible Party):
AGO Study Group
ClinicalTrials.gov Identifier:
NCT01166737
First received: July 16, 2010
Last updated: February 13, 2017
Last verified: February 2017
History of Changes
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)